Back
 PP  Vol.5 No.12 , November 2014
Effects of Vitamin K-1 and Menaquinone-7 on Vascular Function and Blood Pressure in Warfarin-Induced Calcification-Model in Rats
Abstract: Given that vascular calcification is inversely correlated with the clinical intake of menaquinone, a rat model of warfarin-induced calcification may be useful for testing menaquinone and vitamin K-1 potential effects on vascular function. The aim of the present study was to investigate effects of vitamin K-1 and menaquinone-7 treatments on blood pressure and vascular function in warfarin-induced vascular calcification model during five-week intervention in normotensive Wistar-Kyoto rats. Blood pressure was measured weekly, and at the end of the intervention in vitro vascular reactivity measurements were done. Alizarin Red S and von Kossa stainings were used to record possible calcification of aortic sections. Routine clinical chemistry was done from serum and urine samples. Vascular calcification was seen only in a few warfarin-treated animals in histological staining. Warfarin-treatment did not change significantly blood pressure of the rats. Warfarin-treatment increased slightly the endothelium-dependent relaxation of aorta after the L-type calcium channels were blocked. Also the vascular relaxation improved after NOS inhibition in the aorta of the healthy controls and menaquinone-7 treated animals, indicating that the relaxation in those groups was not totally dependent on NO. Clinical chemistry from serum showed some differences in urea, creatinine as well as lipid and glucose metabolism between the healthy controls and warfarin-treated rats.
Cite this paper: Siltari, A. , Wickholm, N. , Kivimäki, A. , Olli, K. , Salli, K. , Tiihonen, K. , Korpela, R. and Vapaatalo, H. (2014) Effects of Vitamin K-1 and Menaquinone-7 on Vascular Function and Blood Pressure in Warfarin-Induced Calcification-Model in Rats. Pharmacology & Pharmacy, 5, 1095-1105. doi: 10.4236/pp.2014.512119.
References

[1]   Kalra, S.S. and Shanahan, C.M. (2012) Vascular Calcification and Hypertension: Cause and Effect. Annals of Medicine, 44, S85-S92.
http://dx.doi.org/10.3109/07853890.2012.660498

[2]   Geleijnse, J.M., Vermeer, C., Grobbee, D.E., Schurgers, L.J., Knapen, M.H.J., van der Meer, I.M., et al. (2004) Dietary Intake of Menaquinone Is Associated with a Reduced Risk of Coronary Heart Disease: The Rotterdam Study. Journal of Nutrition, 134, 3100-3105.

[3]   Beulens, J.W.J., Bots, M.L., Atsma, F., Bartelink, M.-A.E.L., Prokop, M., Geleijnse, J.M., et al. (2008) High Dietary Menaquinone Intake Is Associated with Reduced Coronary Calcification. Atherosclerosis, 203, 489-493.
http://dx.doi.org/10.1016/j.atherosclerosis.2008.07.010

[4]   Gast, G.C.M., de Roos, N.M., Bots, M.L., Beulens, J.W.J., Geleijnse, J.M., Witteman, J.C., et al. (2009) High Menaquinone Intake Reduces the Incidence of Coronary Heart Disease. Nutrition, Metabolism and Cardiovascular Diseases, 19, 504-507.
http://dx.doi.org/10.1016/j.numecd.2008.10.004

[5]   Price, P.A., Faus, S.A. and Williamson, M.K. (1998) Warfarin Causes Rapid Calcification of the Elastic Lamellae in Rat Arteries Heart Valves. Arteriosclerosis, Thrombosis, and Vascular Biology, 18, 1400-1407.
http://dx.doi.org/10.1161/01.ATV.18.9.1400

[6]   Howe, A.M. and Webster, W.S. (2000) Warfarin Exposure and Calcification of the Arterial System of the Rat. International Journal of Experimental Pathology, 81, 51-56.
http://dx.doi.org/10.1046/j.1365-2613.2000.00140.x

[7]   Spronk, H.M.H., Soute, B.A.M., Schungers, L.J., Thijssen, H.H.W., DeMey, J.G.R. and Vermeer, C. (2003) Tissue-Specific Utilization of Menaquinone-4 Results in the Prevention of Arterial Calcification in Warfarin-Treated Rats. Journal of Vascular Research, 40, 531-537.
http://dx.doi.org/10.1159/000075344

[8]   Schungers, L.J., Spronk, H.M.H., Soute, B.A.M., Schiffers, P.M., DeMey, J.G.R. and Vermeer, C. (2007) Regression of Warfarin-Induced Medial Elastocalcinosis by High Inkake of Vitamin K in Rats. Blood, 109, 2823-2831.

[9]   Dao, H.H., Essalihi, R., Graillon, J.-F., Lariviere, R., de Champlain, J. and Moreau, P. (2002) Pharmacological Prevention and Regression of Arterial Remodeling in a Rat Model of Isolated Systolic Hypertension. Journal of Hypertension, 20, 1597-1606.
http://dx.doi.org/10.1097/00004872-200208000-00023

[10]   Essalihi, R., Zandvliet, M.L., Moreau, S., Gilbert, L.-A., Bouvet, C., Lenoel, C., et al. (2007) Distinct Effects of Amlopidine Treatment on Vascular Elastocalcinosis and Stiffness in a Rat Model of Isolated Systolic Hypertension. Journal of Hypertension, 25, 1879-1886.
http://dx.doi.org/10.1097/HJH.0b013e328255e906

[11]   Liu, C.Y., Wan, J.J., Yang, Q.F., Qi, B.L., Peng, W. and Chen, X.L. (2008) Effects of Atorvastatin on Warfarin-Induced Aortic Medial Calcification and Systolic Blood Pressure in Rats. Journal of Huazhong University of Science and Technology, 28, 535-538.
http://dx.doi.org/10.1007/s11596-008-0510-1

[12]   Beazley, K.E., Banyard, D., Lima, F., Deasey, S.C., Nurminsky, D.I., Komoplyannikov, M. and Nurminskaya, M.V. (2013) Transglutaminase Inhibitors Attenuate Vascular Calcification in a Preclinical Model. Arteriosclerosis, Thrombosis, and Vascular Biology, 33, 43-51.
http://dx.doi.org/10.1161/ATVBAHA.112.300260

[13]   Ferland, G. (1998) The Vitamin K-Dependent Proteins: An Update. Nutrition Reviews, 56, 223-230.
http://dx.doi.org/10.1111/j.1753-4887.1998.tb01753.x

[14]   Luo, G., Ducy, P., McKee, M.G., Pinero, G.J., Loyer, E., Behringer, R.R. and Karsenty, G. (1998) Spontaneous Calcification of Arteries and Cartilage in Mice Lacking Matrix GLA Protein. Nature, 386, 78-81.
http://dx.doi.org/10.1038/386078a0

[15]   Danziger, J. (2008) Vitamin K-Dependent Proteins, Warfarin, and Vascular Calcification. Clinical Journal of the American Society of Nephrology, 3, 1504-1510.
http://dx.doi.org/10.2215/CJN.00770208

[16]   Erkkilä, A.T. and Booth, S.L. (2008) Vitamin K Intake and Atherosclerosis. Current Opinion in Lipidology, 19, 39-42.
http://dx.doi.org/10.1097/MOL.0b013e3282f1c57f

[17]   Essalihi, R., Dao, H.H., Yamaguchi, N. and Moreau, P. (2003) A New Model of Isolated Systolic Hypertension Induced by Chronic Warfarin and Vitamin K1 Treatment. American Journal of Hypertension, 16, 103-110.
http://dx.doi.org/10.1016/S0895-7061(02)03204-1

[18]   Lomashvili, K.A., Cobbs, S., Hennigar, R.A., Hardcastle, K.I. and O’Neill, W.C. (2004) Phosphate-Induced Vascular Calcification: Role of Pyrophosphate and Osteopontin. Journal of the American Society of Nephrology, 15, 1392-1401.
http://dx.doi.org/10.1097/01.ASN.0000128955.83129.9C

[19]   Schibler, D., Russell, G.G. and Fleisch, H. (1968) Inhibition by Pyrophosphate and Polyphosphate of Aortic Calcification Induced by Vitamin D3 in Rats. Clinical Science, 35, 363-372.

[20]   Boehm, O., Zu, B., Koch, A., Tran, N., Freyenhagen, R., Hartmann, M. and Zacharowski, K. (2007) Clinical Chemistry Reference Database for Wistar Rats and C57/BL6 Mice. Biological Chemistry, 388, 547-554.
http://dx.doi.org/10.1515/BC.2007.061

[21]   Zhu, D., Mackenzie, N.C., Farquhaarson, C. and Macrae, V.E. (2012) Mechanisms and Clinical Consequences of Vascular Calcification. Frontiers in Endocrinology (Lausanne), 3, 95.
http://dx.doi.org/10.3389/fendo.2012.00095

[22]   Wahlqvist, M.L., Tanaka, K. and Tzeng, B.H. (2013) Clinical Decision-Making for Vitamin K-1 and K-2 Deficiency and Coronary Artery Calcification with Warfarin Therapy: Are Diet, Factor Xa Inhibitors or Both the Answer? Asia Pacific Journal of Clinical Nutrition, 22, 492-496.

 
 
Top